The Department of Health and Social Care has announced that, following an amendment to the voluntary scheme for branded medicines pricing and access agreed between the Department and the Association of the British Pharmaceutical Industry (ABPI), the payment percentage for 2022 has been set at 15%. All other aspects of the voluntary scheme remain unchanged.
According to the Department, the change is made as exceptional growth in total measured sales in 2021 would otherwise have led to a substantial increase in the payment percentage to 19.1%. “Whilst this is evidence of the scheme adjusting for high growth as intended, following engagement with ABPI to understand the impact of this increase and in recognition of the current high levels of uncertainty around underlying sales growth, we have responded to industry’s concerns by reducing the 2022 payment percentage to 15%”, states the Department.
Sources:
www.gov.uk, “Voluntary scheme for branded medicines: payment percentage for 2022”, 20th January 2022